Meddydent Limited 09784284 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is servicing and manufacturing of autoclaves. Digita Accounts Production Advanced 6.30.9574.0 true false true 09784284 2024-04-01 2025-03-31 09784284 2025-03-31 09784284 core:RetainedEarningsAccumulatedLosses 2025-03-31 09784284 core:ShareCapital 2025-03-31 09784284 core:CurrentFinancialInstruments 2025-03-31 09784284 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09784284 core:AdditionsToInvestments 2025-03-31 09784284 core:LandBuildings core:ShortLeaseholdAssets 2025-03-31 09784284 core:MotorVehicles 2025-03-31 09784284 core:PlantMachinery 2025-03-31 09784284 bus:SmallEntities 2024-04-01 2025-03-31 09784284 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09784284 bus:FilletedAccounts 2024-04-01 2025-03-31 09784284 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09784284 bus:RegisteredOffice 2024-04-01 2025-03-31 09784284 bus:Director1 2024-04-01 2025-03-31 09784284 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09784284 core:LandBuildings core:ShortLeaseholdAssets 2024-04-01 2025-03-31 09784284 core:MotorVehicles 2024-04-01 2025-03-31 09784284 core:PlantMachinery 2024-04-01 2025-03-31 09784284 core:Subsidiary1 2024-04-01 2025-03-31 09784284 core:Subsidiary1 1 2024-04-01 2025-03-31 09784284 core:Subsidiary1 countries:AllCountries 2024-04-01 2025-03-31 09784284 countries:EnglandWales 2024-04-01 2025-03-31 09784284 2023-10-01 2024-03-31 09784284 2024-03-31 09784284 core:RetainedEarningsAccumulatedLosses 2024-03-31 09784284 core:ShareCapital 2024-03-31 09784284 core:CurrentFinancialInstruments 2024-03-31 09784284 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 09784284 core:Subsidiary1 1 2023-10-01 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 09784284

Meddydent Limited

Annual Report and Unaudited Financial Statements- Companies house filing

for the Year Ended 31 March 2025

 

Meddydent Limited

Contents

Statement of Financial Position

1

Notes to the Unaudited Financial Statements

2 to 6

 

Meddydent Limited

(Registration number: 09784284)
Statement of Financial Position as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

64,478

-

Investments

5

95

95

 

64,573

95

Current assets

 

Stocks

6

171,168

-

Debtors

7

133,800

-

Cash at bank and in hand

 

92,463

1

 

397,431

1

Creditors: Amounts falling due within one year

8

(40,918)

(95)

Net current assets/(liabilities)

 

356,513

(94)

Net assets

 

421,086

1

Capital and reserves

 

Called up share capital

1

1

Profit and loss account

421,085

-

Shareholders' funds

 

421,086

1

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Income Statement.

Approved and authorised by the Board on 4 December 2025 and signed on its behalf by:
 

.........................................
R D Warren
Director

 

Meddydent Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is: 6 The Lawrence Centre, Oaklands Park, Wokingham, Berkshire, RG41 2FE.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.

The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities.

Government grants

Grants are accounted for under the accruals model as permitted by FRS 102. Grants of a revenue nature are recognised in “other income” within profit or loss in the same period as the related expenditure.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

 

Meddydent Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade debtors

Short term debtors are measured at transaction price, less any impairment.

Cash and cash equivalents

Cash is represented by cash in hand and bank deposits.

Trade creditors

Short term creditors are measured at the transaction price.

Provisions

Provisions are recognised when the company has an obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Employee benefits

 

Meddydent Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Short-term employee benefits are recognised as an expense in the period which they are incurred.

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties and loans to related parties.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 9 (2024 - 1).

4

Tangible assets

Short leasehold land and buildings
£

Plant and machinery
£

Motor vehicles
 £

Total
£

Cost or valuation

Additions

31,148

13,178

49,350

93,676

At 31 March 2025

31,148

13,178

49,350

93,676

Depreciation

Charge for the year

8,356

4,392

16,450

29,198

At 31 March 2025

8,356

4,392

16,450

29,198

Carrying amount

At 31 March 2025

22,792

8,786

32,900

64,478

Included within the net book value of land and buildings above is £22,792 (2024 - £Nil) in respect of short leasehold land and buildings.
 

5

Investments

2025
£

2024
£

Investments in subsidiaries

95

95

 

Meddydent Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Subsidiaries

£

Cost or valuation

Additions

95

Provision

Carrying amount

At 31 March 2025

95

At 31 March 2024

95

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

2025

2024

Subsidiary undertakings

Ascot Autoclaves Ltd.

6 The Lawrence Centre, Oaklands Park, Wokingham, Berkshire, RG41 2FE

UK

Ordinary

95%

95%

6

Stocks

2025
£

2024
£

Work in progress

171,168

-

7

Debtors

Note

2025
£

2024
£

Trade debtors

 

78,102

-

Amounts owed by related parties

17,233

-

Other debtors

 

7,765

-

Prepayments

 

28,143

-

Deferred tax assets

2,557

-

 

133,800

-

 

Meddydent Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

8

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Trade creditors

34,861

-

Taxation and social security

976

-

Other creditors

5,081

95

40,918

95